Maravai LifeSciences Holdings Inc (MRVI)

Christine Dolan currently serves as Executive Vice President and General Manager, Cygnus Technologies at MRVI since January 1, 2024. " " Previously, she served as Chief Operating Officer, Biologics Safety Testing from October 2017 to December 2023. " " "

Kevin Herde is the Chief Financial Officer (CFO) of Maravai LifeSciences Holdings, Inc. since May 2017. " " He brings over 25 years of experience in finance, accounting, and general management, previously serving as the CFO at Sorrento Therapeutics from April 2016 to May 2017. " "

Kurt Oreshack has served as Executive Vice President, General Counsel, and Secretary at Maravai LifeSciences Holdings, Inc. since November 2020, overseeing legal and corporate governance matters. " " Previously, he held roles including Partner at Breakwater Law Group, LLP and General Counsel at Human Longevity, Inc., which bolstered his expertise in corporate law and regulatory compliance. "

Peter Leddy has served as the Chief Administrative Officer at MRVI since June 27, 2022, overseeing HR, DEI, ESG, facilities, and security functions. " " He has extensive prior experience in executive HR roles at companies including Life Technologies and Aloisio Partners. " "

Rebecca Buzzeo is the Executive Vice President and Chief Commercial Officer at MRVI since November 6, 2023. " Previously, she served as Senior Vice President, Chief Commercial Officer and Chief Operating Officer, Nucleic Acid Services from October 17, 2022 to November 5, 2023. "

Benjamin Daverman has been serving as a Director at MRVI since November 2020. " " Previously, he served on the Compensation and Nominating Committee until October 2022 and has extensive experience in healthcare and life sciences, including his current role as Managing Director and Co-Head of the Healthcare Group at GTCR. " "

Constantine Mihas is an experienced leader in the healthcare, pharmaceutical, and life sciences industries. He has served on the Board of Directors at MRVI since November 2020 and previously chaired the Compensation and Nominating Committee until October 2022. " "

Gregory T. Lucier has been a Director on the Board of MRVI since November 2020, bringing over 30 years of leadership experience in the healthcare and life sciences sectors, with previous roles including CEO at Corza Health, Inc. and NuVasive, Inc. " "

Jessica Hopfield, Ph.D., is a seasoned leader in the life sciences industry, serving as a Board Member at MRVI since November 2020 and as Chair of the Nominating, Governance, and Risk Committee since October 2022. " " " She has over two decades of experience and has held independent director roles at companies such as Insulet Corporation and Editas Medicine. " " "

John DeFord, PhD, is a seasoned leader in the healthcare and medical device sectors, currently serving as a Director at MRVI since July 20, 2023. " " He has held key executive and board roles in other companies such as Nordson Corporation and Globus Medical Inc.. " "

Luke Marker has served on the Board of Directors at MRVI since November 2020 and been a member of MLSH 1’s board since 2016. He is currently a Managing Director at GTCR since 2009 and has previous experience in investment banking at Lehman Brothers and Barclays Capital. " " "

Dr. Prahalad has been serving as a Director on the Board of MRVI since November 2020. " " He also leads Iridia, Inc. as President and Chief Executive Officer since November 2019. " "

Robert Andrew Eckert has extensive leadership experience across the healthcare and life sciences sectors, having served as CEO at multiple companies prior to his appointment as Chairman of the Board at MRVI on December 5, 2024. " " " His prior roles include CEO positions at ADAC Laboratories, SumTotal Systems, and several others. "

Sean Cunningham has served as a Director on the Board of Directors of MRVI since November 2020. " " " He is also a member of the Nominating, Governance and Risk Committee since October 2022 and holds active roles outside MRVI, including as a Managing Director and Co-Head of the Healthcare Group at GTCR and as a Board Director at Sotera Health. " "

Susannah Gray has served as a Director at MRVI since November 2020, acting as Chair of the Audit Committee and as a member of the Compensation and Leadership Development Committee. " " " Previously, she served as CFO and later EVP at Royalty Pharma, and held senior roles at CIBC World Markets and Merrill Lynch. " "